Psychiatria pre prax 4/2004
Long-term use of cognitive drugs in Alzheimer disease
The first representative from a group of cholinesterase inhibitors, which are considered standard therapy of Alzheimer disease, came on our market already in 1997. But still, there are insufficient numbers of treated patients in comparison with other advanced countries. Article summarises basic rules of cholinesterase inhibitors administration based on a review of the literature and recommendations and with regards to the experiences of author.
Keywords: Alzheimer disease, cholinesterase inhibitors, memantine, rules of administration.
